IDI Hanpakot in the First Quarter: Debt Rests on Strong Insurance Profitability and Limited Capital Headroom
IDI Hanpakot's first quarter barely changes the issuing company itself, but it updates the safety layer behind it: IDI Insurance produced strong underwriting profit, distributed NIS 140 million, and still reported a 134% solvency ratio.
The first quarter of IDI Hanpakot should not be read through its own earnings, because those earnings say almost nothing about the quality of the debt. The company remains an issuance conduit: money raised from bondholders is placed as deferred deposits with IDI Insurance, and the issuer's finance costs are almost mirrored by finance income from the parent. The important change therefore sits one level above it: IDI Insurance kept comprehensive net profit at NIS 89 million, improved insurance service profit, and reported a 134% economic solvency ratio even after NIS 140 million of dividends were deducted from eligible own funds. That is a better picture than an immediate pressure scenario, but it still has friction: profitability is heavily concentrated in general insurance, especially comprehensive and third-party motor, life insurance moved to a loss, operating cash flow was negative because of one-off payments and tax advances, and Tier 2 capital is already hitting recognition limits. For debt holders, the point is not that the risk disappeared. The quarter buys time and comfort before two near-term checks: whether underwriting profit can hold under tariff oversight and claims volatility, and whether the group reaches late 2026 with a clear decision on Series V in a cost-of-capital environment far above the one in which that series was issued.
The Company Is a Debt Conduit, Not a Standalone Insurance Business
IDI Hanpakot is one of those companies where the bottom line can mislead precisely because it looks too clean. Its shares are not listed for trading, it has no standalone insurance activity, and it does not take operating credit. Its role is to issue subordinated debt certificates and deposit the proceeds as deferred deposits with IDI Insurance, on terms identical to the issued debt.
That structure creates almost no economic profit at the issuer level. In the first quarter, finance income totaled NIS 5.307 million, and finance expenses on the debt certificates totaled the same amount. Net profit for the period was only NIS 6 thousand, compared with NIS 13 thousand in the corresponding quarter. The NIS 864 thousand equity deficit also comes from applying IFRS 9 to the deferred deposits, not from a normal operating loss.
That is why analyzing the issuer like a regular insurer misses the point. Its main asset is NIS 500.3 million of deferred deposits with the parent, against NIS 501.6 million of debt certificates, and the interest matching between the two sides leaves holders with exposure that is almost directly tied to IDI Insurance's capital quality.
Deep TASE's previous annual analysis of IDI Hanpakot made the same point: the 2025 refinancing pushed out the immediate pressure, but did not create an independent earnings engine. The current quarter confirms that line. What changed is not the issuer's model, but the quality of the protection sitting at the parent.
The Quarter Strengthened the Parent, but Not Evenly
IDI Insurance reported comprehensive net profit of NIS 89 million in the quarter, almost identical to the corresponding quarter, and comprehensive pre-tax profit of NIS 136.5 million versus NIS 137.0 million. That sounds stable, but the mix matters more than the total: insurance service profit rose to NIS 145.4 million from NIS 131.4 million, while finance expenses from insurance contracts rose because of the yield curve.
That means the quarter is not merely a capital-markets result or an accounting release. The insurance business itself improved, especially in general insurance. For IDI Hanpakot debt holders, that is positive, because they depend on the parent continuing to hold capital, distribute cautiously, and preserve access to the debt market. But the composition of profit also shows the yellow flag: general insurance carries most of the improvement, while life insurance moved to a comprehensive pre-tax loss.
General insurance is the anchor. Comprehensive pre-tax profit in the segment jumped to NIS 110.2 million, up 42%. Within the segment, comprehensive and third-party motor again carried the center: comprehensive pre-tax profit reached NIS 83.7 million, compared with NIS 58.0 million in the corresponding quarter, and the gross and retained combined ratio fell to 83% from 90%. That is real underwriting improvement.
Still, the quality of growth in motor is not simple. Gross premiums in comprehensive and third-party motor fell 20% from the corresponding quarter, and fell 7% excluding the Accountant General tender, even though the number of policies sold increased 4%. The business explanation is lower prices following a decline in theft risk and market competition. The profitability improvement therefore does not come from broad price increases. It comes from lower claims and positive development of prior periods. That can hold, but it is more exposed to changes in claims, spare-parts prices, and tariff supervision.
Compulsory motor improved too, but it is smaller for the thesis. Comprehensive pre-tax profit rose to NIS 11.3 million from NIS 8.5 million, and insurance service profit reached NIS 7.9 million. In health insurance, comprehensive pre-tax profit rose to NIS 6.9 million after an improvement in the claims ratio. In contrast, life and savings moved to a comprehensive pre-tax loss of NIS 15.2 million, mainly because of an unusual claims ratio and higher finance expenses from insurance contracts.
Motor Tariff Supervision Is Part of the Thesis
The Deep TASE analysis published in early May on IDI's motor insurance focused on approval of the new comprehensive and third-party motor tariff. The current quarter gives that issue better context: the most profitable business line at IDI Insurance is also the line where the regulator already required renewed tariff approval.
On November 25, 2025, the Capital Markets Authority required eight insurers, including IDI Insurance, to resubmit motor insurance tariffs for approval so that they fit the underlying risk. On May 3, 2026 at 11:45, the authority notified the company that it could not market comprehensive and third-party motor policies from May 1 because a new tariff had not been approved by April 30. On the same day at 23:00, approval was received and the restriction was removed. The new tariff must apply to policies starting no later than August 1, 2026.
The event closed quickly, but it was not noise. If comprehensive and third-party motor generated NIS 83.7 million of comprehensive pre-tax profit in one quarter, any limit on pricing, discounts, or claims payment mechanics can change the quality of the profit that supports the whole debt layer. The May 2026 draft determination on reduced payments to third parties for spare-parts price differences belongs to the same regulatory family. The company expects no material impact in its current form, but the sequence of interventions shows that motor profitability is not operating in a fully free pricing space.
The legal notes reinforce the same point. Provisions for all pending legal claims totaled about NIS 118 million at the end of the quarter, compared with about NIS 113 million at the end of 2025. The stated claimed amounts in pending proceedings reach about NIS 880 million, although the company emphasizes that this is the amount claimed by plaintiffs and not its estimate of exposure. The more important proceeding for risk quality remains the automatic renewal claim in motor property insurance, where the company estimates exposure of about NIS 36 million before tax if the judgment is not canceled or materially changed on appeal. That is not a standalone debt-threatening risk, but it explains why high profitability in motor is not the same as frictionless net income.
The Solvency Buffer Clears the Target, but Dividends Are Already in the Math
The most supportive number for IDI Hanpakot's debt is IDI Insurance's solvency ratio. As of December 31, 2025, the Solvency II economic ratio was 134%, compared with a board target of 120%. Excess own funds over the SCR stood at NIS 523.1 million, and excess above the board target stood at NIS 218.5 million. That figure already includes dividends declared after the calculation date: NIS 75 million in March 2026 and another NIS 65 million in May 2026.
That matters. One of the open questions after the previous quarter was whether dividends would start to compress the margin above the 120% target. The updated answer is cautiously positive: even after NIS 140 million of dividends, the ratio remains 134%, and excess above the board target stands at NIS 218.5 million versus NIS 200.7 million in 2024 after capital actions. In headline terms, the capital cushion did not erode. But the NIS 65 million dividend approved in May equals about 73% of first-quarter profit, so the distribution policy still needs to be measured against recurring underwriting profitability, not just one strong quarter.
| Capital and Cash Metric at IDI Insurance | Latest Figure | What It Means for Debt Holders |
|---|---|---|
| Economic solvency ratio | 134% | Above the board target, but not an exceptional margin for a leveraged insurer |
| Excess above the 120% target | NIS 218.5 million | A more comfortable cushion than 2024, after deducting declared dividends |
| Dividends declared after December 31, 2025 | NIS 140 million | A meaningful share of profit is returned to owners, not kept entirely in solvency capital |
| Operating cash flow in the quarter | Negative NIS 95.3 million | Mostly from a one-off National Insurance Institute payment and tax advances, but it reminds investors that profit is not always available cash |
On an all-in cash flexibility basis, after actual cash uses, the quarter looks weaker than profit. IDI Insurance's cash balance fell from NIS 277.0 million at the start of the year to NIS 153.1 million at the end of March, and operating cash flow was negative NIS 95.3 million, compared with positive NIS 221.4 million in the corresponding quarter. The company attributes the gap mainly to a one-time settlement payment to the National Insurance Institute and higher income tax advances. That does not prove structural cash weakness, but it prevents the simple conclusion that high quarterly profit immediately equals higher cash flexibility.
The debt layer itself also shows that the 2025 refinancing did not solve the cost-of-capital question. Series V carries a 2.18% annual coupon on NIS 164.4 million par value, and Series Z carries a 5.13% coupon on NIS 340.6 million. Both series are unlinked, and both have early redemption rights. For Series V, the first call comes five years after the December 2021 issuance, making late 2026 a key point. If the company does not exercise the call, holders receive additional interest equal to 50% of the original risk spread for the remaining period.
The Next Few Quarters Will Test Profit Quality, Not the Issuer
The first quarter improves IDI Hanpakot's starting point as a debt instrument, but it does not change the fact that the issuer depends almost entirely on the insurance parent. The positive evidence is higher parent-level underwriting profit, a solvency ratio above target after meaningful distributions, and no sign of deferral circumstances or an immediate debt-service problem. The cautious evidence is that profit depends heavily on motor insurance, a regulated business line exposed to tariff supervision, litigation, and claims volatility.
The next few quarters need to show three things: a low combined ratio in comprehensive and third-party motor after the new tariff is implemented, comfortable surplus above the 120% target after further distributions, and clarity on Series V ahead of late 2026. Until then, the conclusion is that the debt strengthened because of the parent, not because anything changed at the issuer. IDI Insurance still provides the profitability and capital that support IDI Hanpakot's conduit, but that safety rests on one insurance parent, a profitable but supervised motor line, and a new debt-cost environment that has not yet been tested through Series V.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.